FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Teva Pharmaceuticals Sunitinib Malate Capsules Recall

Sunitinib Malate Capsules, 12

Teva Pharmaceuticals USA Inc · Parsippany, NJ

Risk level
Class II
Reported by FDA
Jul 19, 2023
Recall ID
D-0913-2023
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Sunitinib Malate Capsules starting Jul 5, 2023. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0913-2023 on Jul 19, 2023. Reason: Failed Moisture Limits: Water (moisture) content above the approved product specifications. Status: Terminated.

Why it was recalled

Failed Moisture Limits: Water (moisture) content above the approved product specifications.

Product description

Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28

Lot numbers, UPCs & expiration codes

Lot # 100037220, Exp 10/2024

Where it was sold

Product was distributed to 3 wholesalers/distributors who further distributed the product Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0913-2023
Classification
Class II
Status
Terminated
Recall initiated
Jul 5, 2023
FDA report date
Jul 19, 2023
Quantity
180 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA Inc

Original FDA data

Every field from FDA enforcement report D-0913-2023, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
92636
Address
400 Interpace Pkwy Bldg A
Code information
Lot # 100037220, Exp 10/2024
Postal code
07054-1120
Report date
Jul 19, 2023
Product type
Drugs
Recall number
D-0913-2023
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA Inc
Product quantity
180 bottles
Termination date
Jan 10, 2024
Reason for recall
Failed Moisture Limits: Water (moisture) content above the approved product specifications.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Sunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0093-8199-28
Distribution pattern
Product was distributed to 3 wholesalers/distributors who further distributed the product Nationwide in the USA.
Recall initiation date
Jul 5, 2023
Initial firm notification
Letter
Center classification date
Jul 11, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0913-2023, published Jul 19, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls